The FDAs compounding rules placed BPC-157 in a category of bulk substances that may present significant safety risks, which heavily restricts compounding pharmacies from making it
My version of the idea was that the employer would mostly just facilitate and look like a hero but Andel took it one step further: Employers contribute directly per fill, which honestly makes more sense when you look at what it costs them not to
In both groups, studies published in the Journal of Sexual Medicine and the International Journal of Impotence Research found that PT-141 improved sexual desire, arousal, and penile erection rigidity
But every now and then, its worth stepping back and just clarifying the landscape
Aging Cell, 2021, 20 (2), e13303